1. Home
  2. AGD vs MXCT Comparison

AGD vs MXCT Comparison

Compare AGD & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGD
  • MXCT
  • Stock Information
  • Founded
  • AGD 2006
  • MXCT 1999
  • Country
  • AGD United Kingdom
  • MXCT United States
  • Employees
  • AGD N/A
  • MXCT N/A
  • Industry
  • AGD Trusts Except Educational Religious and Charitable
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AGD Finance
  • MXCT Health Care
  • Exchange
  • AGD Nasdaq
  • MXCT Nasdaq
  • Market Cap
  • AGD 255.9M
  • MXCT 239.2M
  • IPO Year
  • AGD N/A
  • MXCT 2021
  • Fundamental
  • Price
  • AGD $10.62
  • MXCT $2.06
  • Analyst Decision
  • AGD
  • MXCT Strong Buy
  • Analyst Count
  • AGD 0
  • MXCT 1
  • Target Price
  • AGD N/A
  • MXCT $9.00
  • AVG Volume (30 Days)
  • AGD 61.2K
  • MXCT 922.0K
  • Earning Date
  • AGD 01-01-0001
  • MXCT 08-05-2025
  • Dividend Yield
  • AGD 8.13%
  • MXCT N/A
  • EPS Growth
  • AGD N/A
  • MXCT N/A
  • EPS
  • AGD N/A
  • MXCT N/A
  • Revenue
  • AGD N/A
  • MXCT $37,675,000.00
  • Revenue This Year
  • AGD N/A
  • MXCT $8.82
  • Revenue Next Year
  • AGD N/A
  • MXCT $21.12
  • P/E Ratio
  • AGD N/A
  • MXCT N/A
  • Revenue Growth
  • AGD N/A
  • MXCT N/A
  • 52 Week Low
  • AGD $8.20
  • MXCT $2.03
  • 52 Week High
  • AGD $9.78
  • MXCT $5.20
  • Technical
  • Relative Strength Index (RSI)
  • AGD 67.48
  • MXCT 39.29
  • Support Level
  • AGD $10.55
  • MXCT $2.19
  • Resistance Level
  • AGD $10.70
  • MXCT $2.28
  • Average True Range (ATR)
  • AGD 0.09
  • MXCT 0.12
  • MACD
  • AGD 0.01
  • MXCT 0.00
  • Stochastic Oscillator
  • AGD 84.44
  • MXCT 7.81

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: